• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Tusen takk! MSF-Norway and DNDi gather a record NOK 266 million during the televised Norwegian solidarity campaign TV-Aksjonen

‘We are making medical history.’

Home > News

Tusen takk! MSF-Norway and DNDi gather a record NOK 266 million during the televised Norwegian solidarity campaign TV-Aksjonen

‘We are making medical history.’

MSF, DNDi, and TV presenters celebrating the end of the event
Norway — 25 Oct 2022

A head-spinning week full of public events, charity concerts, benefit auctions, broadcasts, and door-to-door donations in Norway concluded on Sunday evening with a fantastic news: Médecins Sans Frontières (MSF) and DNDi have raised a total of NOK 266.202.750 during the annual Norwegian solidarity campaign TV-Aksjonen – the highest amount ever donated through the event.

Dr Bernard Pécoul and Lindis Hurum in the TV studio
Dr Bernard Pécoul in the NRK TV studio with Lindis Hurum, General Secretary of MSF in Norway

‘We are making medical history,’ said Lindis Hurum, General Secretary of MSF in Norway, during a live broadcast at NRK, the TV channel organizing the fundraiser. ‘This investment will save lives,’ added DNDi Founder Bernard Pécoul, who came to Oslo for the campaign.

Dr Pécoul was joined in Norway by Luke Kanyang’areng’, a former visceral leishmaniasis patient from Kenya. Luke is working as a nurse in the same clinic where doctors saved his life 30 years ago, when he was still a young boy. He came to Oslo from Nairobi – his first trip to Europe – to carry the voice and the hopes of the millions of neglected patients.

Luke Kanyang’areng’ in the NRK TV studio

‘The treatment was terrible, and we were going through a lot of pain. Even sitting down or walking was a problem,’ he said of the treatment he received as a kid, during a live interview on NRK P3 radio . ‘Injections are very painful, and you must get them for 30 days, every day. I cried a lot.’

‘What DNDi is doing is wonderful,’ Luke said. ‘They are doing research to find a better, cheaper treatment – a simpler treatment to take. They work towards achieving oral medication, so that, if you are a school-going child, you can still take your medication, not missing classes – not the way I did. We really appreciate what DNDi is doing.’ 

Luke in the NRK P3 radio studio

TV-Aksjonen is considered the world’s largest fundraiser in terms of donations per capita. The 2022 edition, under the slogan ‘borderless diseases – forgotten patients’, aimed at supporting MSF and DNDi’s fight against deadly diseases, including sleeping sickness and visceral leishmaniasis.

DNDi was founded in 2003 by MSF and medical research organizations in Brazil, India, Kenya, and Malaysia. These organizations have since developed together several life-saving medicines for neglected patients; but a lot remains to be done. In an opinion piece, MSF doctor Morten Rostrup reflected on his experience with sleeping sickness patients in the Democratic Republic of Congo, and the lack of medical research for the most vulnerable: ‘It is great to know that patients with the disease can now be safely treated; but still, we are far from the goal of correcting the imbalance which is still unfortunately there.’

The solidarity campaign involved the charity auction of diverse items, including a signed guitar from the Norwegian singer and songwriter Girl in Red, a signed racket and headband from tennis player Casper Ruud, and… a 100-year-old olive tree.

In Oslo, Luke and Bernard joined the tens of thousands of volunteers who went door-to-door in the cold to collect individual donations. Bernard also accompanied the Mayor of Oslo, Marianne Borgen, to ring at doors, his donation mug in hand.

Dr Bernard Pécoul and Marianne Borgen, Mayor of Oslo, going door to door asking for donations. Photo credit: Ann Kristin Pettersen
Luke with Dr Chinonso Emmanuel Okorie, a MSF doctor from Nigeria, collecting individual donations. Photo credit: Marte Woxen Burum / MSF Norway

Through TV-Aksjonen, the Norwegian government donated NOK 50 million to DNDi to support our efforts to develop better treatments for sleeping sickness and visceral leishmaniasis.

‘After two years [marked by the] pandemic, it is crystal clear that serious infectious diseases are affecting everyone on the planet and that diseases know no borders. That is why this year’s TV campaign is so important,’ said Norwegian Minister of International Development Anne Beathe Tvinnereim.

From left to right: TV presenter Anne Rimmen, General Secretary of MSF in Norway Lindis Hurum, Minister of International Development of Norway Anne Beathe Tvinnereim, DNDi Founder Dr Bernard Pécoul

‘The market alone is unable to offer affordable vaccines and medicines to the people who need it the most,’ said Anniken Huitfeldt, the Minister of Foreign Affairs, who also took part of the campaign. ‘Many health crises and humanitarian crises do not get the attention they should.’

We would like to thank MSF for inviting us to join this extraordinary event. We are truly humbled by the generosity of so many people who are volunteering their time, learning about MSF and DNDi’s activities, reaching out to neighbours, and organizing their communities to support our work.

Their outstanding help will bring us closer to our goal of developing better, safe, affordable, and accessible medicines for the most neglected. Thank you so much!

Dr Bernard Pécoul with Dr Chinonso Emmanuel Okorie and Lindis Hurum

Photo credit: Marion Mossing / MSF Norway

Funding Partnership Norway

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License